Ani Pharmaceuticals (ANIP) Tax Rate (2012 - 2026)
Ani Pharmaceuticals' (ANIP) quarterly Tax Rate came in at 33.43% in Q2 2026, up 1442.0% year-over-year from 2.17% in Q2 2025, and up 25.31% quarter-over-quarter from 26.68% in Q1 2026.
Analysis
Ani Pharmaceuticals (ANIP) Tax Rate (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has disclosed Tax Rate across 15 years of filings, most recently posting 33.43% for Q2 2026.
- In Q2 2026, Tax Rate rose 1442.0% year-over-year to 33.43%; the TTM figure through Jun 2026 stood at 24.04% (down 655.0% YoY), while the FY2025 annual figure was 18.22%, up 161.0% from the prior year.
- Tax Rate came in at 33.43% for Q2 2026 at Ani Pharmaceuticals, up from 26.68% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 33.43% in Q2 2026 to a low of 21.96% in Q4 2023.
- Average Tax Rate over 5 years is 18.56%, with a median of 22.39% recorded in 2022.
- Year-over-year, Tax Rate tumbled 4761 bps in 2023 and surged 4729 bps in 2024.
- Over 5 years, Tax Rate stood at 25.65% in 2022, then tumbled by 186 bps to 21.96% in 2023, then jumped by 215 bps to 25.33% in 2024, then plunged by 50 bps to 12.56% in 2025, then jumped by 166 bps to 33.43% in 2026.
- Per Business Quant data, the three most recent Tax Rate figures were 33.43% in Q2 2026, 26.68% in Q1 2026, and 12.56% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | -26.59% |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | -85.63% |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 21.32% |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 1.94% |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 25.29% |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.09% |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 33.43% |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 21.26% |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 2.08% |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.43% |
| Mar 31, 2026 | 26.68% |
| Dec 31, 2025 | 12.56% |
| Sep 30, 2025 | 21.30% |
| Jun 30, 2025 | 19.00% |
| Mar 31, 2025 | 21.54% |
| Dec 31, 2024 | 25.33% |
| Sep 30, 2024 | 23.28% |
| Mar 31, 2024 | 28.13% |
| Dec 31, 2023 | -21.96% |
| Sep 30, 2023 | 13.90% |
| Jun 30, 2023 | -19.05% |
| Mar 31, 2023 | 33.00% |
| Dec 31, 2022 | 25.65% |
| Sep 30, 2022 | 29.64% |
| Jun 30, 2022 | 20.72% |
| Mar 31, 2022 | 22.39% |
| Dec 31, 2021 | 21.77% |
| Sep 30, 2021 | 37.87% |
| Jun 30, 2021 | 22.23% |